Laura A. Philips
CIK: 0001401312
Transaction Breakdown
Open Market Buys (P)0 (0.0%)
High conviction signal
Open Market Sales (S)0 (0.0%)
Position reduction
Option Exercises (M)0 (0.0%)
Derivative conversions
Awards (A)1 (100.0%)
Compensation grants
Other (G, F, J, C, D, …)0 (0.0%)
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Companies & Roles (1)
NIKI
Niki BioSolutions, Inc.
Director
Discretionary Trading P&L
Holdings
About Philips Laura A
Philips Laura A (SEC CIK 0001401312) files insider reports with the SEC as Director of Niki BioSolutions, Inc. (NIKI).
Signal8 holds 2 ownership filings by Philips Laura A (1 Form 3, 1 Form 4), filed between Jul 24, 2026 and Oct 21, 2026. Those filings report 1 transaction, the latest on Jul 22, 2026. Signal8's Form 4 history starts in Sep 2024.
The business address on Philips Laura A's filings is in PRINCETON, NJ.
Recent filings by Philips Laura A
- Jul 22, 2026: Grant or award of NIKI derivative securities (Form 4, code A).
Other insiders filing for Niki BioSolutions, Inc. (NIKI)
- Sheinerman Kira, Director
- Arner Douglas Wayne, Director
- Wu Justin Che Yuen, Director
- Mireskandari Alidad, President, & COO